|
FY2023
12 months to Dec 31, 2024
|
FY2022
12 months to Dec 31, 2023
|
FY2021
12 months to Dec 31, 2022
|
FY2020
9 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash Flows From Operating Activities: | ||||
| Net income (loss) | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||
| Investment income earned on investments held in the Trust Account | ||||
| Investment income earned on cash and investments held in the Trust Account | ||||
| Change in fair value of derivative liabilities | ||||
| Change in fair value of convertible promissory note - related party | ||||
| Change in fair value of convertible promissory note - related parties | ||||
| Gain on waiver of deferred underwriting commission | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | ||||
| Other current assets | ||||
| Other assets | ||||
| Accounts payable and accrued expenses | ||||
| Net Cash Used In Operating Activities | ||||
| Cash Flows From Investing Activities: | ||||
| Cash deposited into Trust Account | ||||
| Cash withdrawn from Trust Account for redemptions | ||||
| Net Cash Provided By Investing Activities | ||||
| Cash Flows From Financing Activities: | ||||
| Proceeds from related party payables | ||||
| Payments made in relation to redemption of Class A ordinary shares | ||||
| (Repayments of) advances from related party payables | ||||
| Proceeds from convertible promissory notes – related parties | ||||
| Payment of offering costs | ||||
| Net Cash Used In Financing Activities | ||||
| Net change in cash | ||||
| Cash at beginning of period | ||||
| Cash at end of period | ||||
| Supplemental disclosure of non-cash financing activities: | ||||
| Current period accretion to redemption value | ||||
| Proceeds received in excess of fair value of promissory note | ||||
| Underwriting Fee Waiver | ||||
Loading...